Abstract
The impact of hypertension is a major contributor to the largely uncontrolled, global disease burden across all racial/ethnic groups. African-Americans have a higher incidence and prevalence of hypertension compared with Caucasians. End-organ manifestations continue to be multi-factorial and have been closely associated with salt sensitivity, obesity, and overactivity of the sympathetic nervous system as well as environmental influences. Despite the advances in the treatment of hypertension, there continues to be a disproportionate burden among racial and ethnic minorities. There is compelling evidence that African-Americans are more susceptible to increased salt load compared to Caucasians, resulting from alterations in kidney function that requires higher arterial pressure to maintain steady-state, causing a shift to the right of the pressure–naturesis curve. In molecular genetic studies on salt sensitivity, several molecular variants have been identified by single strand nucleotides polymorphisms to be more exclusive in blacks than in whites. As a result of having sympathetic overactivity from obesity, there is a compensatory mechanism to burn fat and decrease weight gain, but in exchange for an increased sympathetic discharge to the peripheral vasculature which may predispose on to hypertension.
The African American Heart Failure Trial (A-HeFT) suggested that African-Americans with congestive heart failure demonstrated improvement in morbidity and mortality when added to a fixed-combination therapy of isosorbide dinitrate and hydralazine. This study also supports the implications of a nitric oxide deficiency contribution to a higher cardiovascular burden in African-Americans. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) was also one of the first to compare the effectiveness of different classes of antihypertensive therapy; a calcium channel blocker (amlodipine), ACE inhibitor (lisinopril), or an alpha-blocker (doxazosin) were individually compared to a diuretic (chlorthalidone) to reduce fatal or non-fatal coronary heart disease on a diverse population (40,386 study participants) with sufficient power to analyze ethnic groups, especially blacks. The African-American Study of Kidney Disease (AASK) examined the effect of aggressive blood pressure control on progression of renal failure in 1094 African-Americans. One of the largest cohort studies addressing African-Americans and lifestyle modification occurred in the Dietary Approach to Stop Hypertension (DASH) designed to assess the effects of dietary pattern on blood pressure. The Heart and Stroke Statistical Update 2007 states that 70 million people experience a new or recurrent stroke each year. African-Americans may be prone to a higher risk of lacunars infarctions and large artery intracranial occlusive disease, whereas whites may be prone to cerebral embolism, and transient ischemic attack.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. ata from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60–69.
Joint National Committee on Prevention, Disease, Detection, Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413–2446.
The AHA Statistic Update Writing Group. Heart Disease and Stroke Statistics 2007 Update. A Report from the American Heart Association Committee and Stroke Statistics Subcommitte. Circulation 2007; 115:e69–171.
Gu Q, Paulose-Ram R, Dillion C, et al. Antihypertensive medication use among U.S. adults with hypertension. Circulation 2006; 113:213–221.
Centers for Disease Control. Health Disparities experienced by Blacks or African Americans – United States. MMWR 2005; 54(1):1–3.
Peters RM, Flack JM. Salt sensitivity and hypertension in African Americans: implications for cardiovascular nurses. Prog Cardiovasc Nurs 2000; 15 (4):138–144.
Ambrosius WT, Bloem LJ, Zhou L, et al. Genetic variants in the epithelial sodium channel in relation to aldosterone and potassium excretion and risk for hypertension. Hypertension 1999; 34:631–637.
Pratt HJ. Central role for ENaC in development of hypertension. J Am Soc Nephrol 2005; 16:3154–3159.
Pratt HJ, Ambrosius WT, Agarwal R, et al. Racial difference in the activity of the amiloride-sensitive epithelial sodium channel. Hypertension 2002; 40:903–908.
Eslami P, Tuck M. The role of sympathetic nervous system in linking obesity with hypertension in whites versus black Americans. Curr Hypertens Rep 2003; 5:269–272.
Abate NI, Mansour YH, Meryem T, et al. Overweight and sympathetic overactivity in Black Americans. Hypertension 2001; 38:379–383.
Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African American to vascular diseases. Circulation 2004; 109:2511–2517.
Mason, PR, Kalinowski L, Jacob RF, et al. Nebivolol reduces nitric stress and restores nitric oxide bioavailability in endothelium of Black Americans. Circulation 2005; 112:3795–3801.
Taylor AL, Zieche S, Yancy C, et al., for the African American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralizine in blacks with heart failure. N Engl J Med 2004; 351:2049–2057.
Suthanthriran M, Li B, Song JO, et al. Transforming growth factor-β1 hyperexpression in African American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 2000; 97:3479–3484.
Douglas J, Bakis G, Epstein M, et al., the Hypertension in African Americans Working Group. Management of high blood pressure in African Americans. Arch Intern Med 2003; 163:525–540.
Ferdinand KC. African American heart failure trial: role of endothelial dysfunction and heart failure in African Americans. Am J Card 2007; 99:3d–6d.
Agodoa LY, Appel L, Bakris GL, et al., African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs. amlodipine on renal outcomes in hypertensive nephroscelorsis: a randomized controlled trial. JAMA 2001; 285(21): 2719–2728.
Davis BR, Culter JA, Gordon DJ, et al., for the ALLHAT Research Group. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Am J Hypertens 1999; 9:342–362.
Gillum RF. Stroke mortality in blacks. Stroke 1999; 30:1711–1715.
Appel LJ, Moore TJ, Obarzanek E, et al., for the DASH Collaborative Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336: 1117–1124.
Stansbury JP, Jia H, Williams LS, et al. Ethnic disparities in stroke epidemiology, acute care, and postacute outcomes. Stroke 2005; 36:374–387.
Hauser WA, Paik MC, Shea S. Race-ethnic disparities in the impact of stroke risk factors: the Northern Manhattan Stroke Study. Stroke 2001; 32:1725–1731.
Duke Med News. Study finds gene is associated with higher risk of one kind of stroke among African Americans; 1998, Feb 6 (http://www.dukemednews.org/news/article.php?id=623).
Song Q, Cole JW, O’Connel JR, et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Gene 2006; 15:2468–2478.
Kissela B, Schneider A, Kleindorfer D, et al. Stroke in a biracial population. The excess burden of stroke among blacks. Stroke 2004; 35:426–431.
Katzan IL, Hammer MD, Furlan AJ, et al., on behalf of the Cleveland Clinic Health System Stroke Quality Improvement Team. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke. A Cleveland update. Stroke 2003; 34:799–800.
Gorelick PB, Richardson D, Kelly M, et al. on behalf of the African American Antiplatelet Stroke Prevention Study Investigators. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 2003; 289 M(22):2947–2957.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jamerson, K.A., Corbin, T.L. (2009). Hypertension and Stroke in Racial/Ethnic Groups. In: Ferdinand, K.C., Armani, A. (eds) Cardiovascular Disease in Racial and Ethnic Minorities. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-410-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-410-0_6
Publisher Name: Humana Press
Print ISBN: 978-1-58829-981-9
Online ISBN: 978-1-59745-410-0
eBook Packages: MedicineMedicine (R0)